Article
Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.
Clinical and experimental immunology - 1 Jun 2007
Clausen J, Wolf D, Petzer A L, Gunsilius E, Schumacher P, Kircher B, Gastl G, Nachbaur D
Abstract excerpt
To define the role of quantitative graft composition and donor killer-cell immunoglobulin-like receptor (KIR) genotype in clinical outcome following unmanipulated peripheral blood stem cell transplantation (PBSCT) from human leucocyte antigen (HLA)-identical siblings, 43 consecutive transplants for haematological malignancies were analysed retrospectively. Twenty-four patients underwent myeloablative conditioning...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.